Rbc Sciences Biologiques Fund Total Asset
| 0P00007138 | CAD 54.94 0.18 0.33% |
RBC sciences biologiques fundamentals help investors to digest information that contributes to RBC Sciences' financial success or failures. It also enables traders to predict the movement of RBC Fund. The fundamental analysis module provides a way to measure RBC Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RBC Sciences fund.
RBC |
RBC sciences biologiques Fund Total Asset Analysis
RBC Sciences' Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current RBC Sciences Total Asset | 489.52 M |
Most of RBC Sciences' fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RBC sciences biologiques is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Based on the latest financial disclosure, RBC sciences biologiques has a Total Asset of 489.52 M. This is much higher than that of the RBC Global Asset Management Inc. family and significantly higher than that of the US Equity category. The total asset for all Canada funds is notably lower than that of the firm.
RBC Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RBC Sciences' direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the funds which would be a good addition to a portfolio. Peer analysis of RBC Sciences could also be used in its relative valuation, which is a method of valuing RBC Sciences by comparing valuation metrics of similar companies.RBC Sciences is currently under evaluation in total asset among similar funds.
Fund Asset Allocation for RBC Sciences
The fund consists of 97.28% investments in stocks, with the rest of investments allocated between different money market instruments.Asset allocation divides RBC Sciences' investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
RBC Fundamentals
| Total Asset | 489.52 M | |||
| One Year Return | 29.16 % | |||
| Three Year Return | 16.88 % | |||
| Five Year Return | 14.13 % | |||
| Ten Year Return | 17.57 % | |||
| Net Asset | 489.52 M | |||
| Minimum Initial Investment | 500 | |||
| Cash Position Weight | 2.72 % | |||
| Equity Positions Weight | 97.28 % |
About RBC Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RBC sciences biologiques's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RBC Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RBC sciences biologiques based on its fundamental data. In general, a quantitative approach, as applied to this fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with RBC Sciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if RBC Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RBC Sciences will appreciate offsetting losses from the drop in the long position's value.Moving together with RBC Fund
| 0.9 | 0P0000OXA6 | PHN Multi Style | PairCorr |
| 0.81 | 0P000077P2 | RBC Dividend | PairCorr |
| 0.85 | 0P0000716B | Mawer Equity A | PairCorr |
| 0.94 | 0P000071W8 | TD Index Fund | PairCorr |
The ability to find closely correlated positions to RBC Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace RBC Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back RBC Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling RBC sciences biologiques to buy it.
The correlation of RBC Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as RBC Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if RBC sciences biologiques moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for RBC Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in RBC Fund
RBC Sciences financial ratios help investors to determine whether RBC Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RBC with respect to the benefits of owning RBC Sciences security.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |